Structure Therapeutics Inc. American Depositary Shares (GPCR) Stock
NASDAQ · GPCR
36.81
Fundamentals
Market cap
$2.50B
Price / Earnings ratio
-11.6x
Price / Sales ratio
N/A
Price / Book ratio
1.8x
Return on assets
-0.1%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Structure Therapeutics Inc. American Depositary Shares
No description available.
SectorHealthcare
IndustryBiotechnology
Employees281
CEODr. Raymond C. Stevens Ph.D.
IPO DateFeb 3, 2023
HeadquartersSouth San Francisco, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Raymond C. Stevens Ph.D. | CEO & Director | 1964 |
| Mr. Jun S. Yoon | Co- Founder, CFO & Secretary | 1978 |
| Dr. Yingli Ma Ph.D. | Chief Technology Officer | 1974 |
| Dr. Xichen Lin Ph.D. | Chief Scientific Officer & GM of Structure Shanghai | 1974 |
| Dr. Blai Coll M.D., Ph.D. | Chief Medical Officer | 1974 |
| Mr. Matthew Lang J.D. | COO & General Counsel | 1976 |
| Mr. Bob Gatmaitan | Senior Vice President of People | — |
| Dr. Hui Lei Ph.D. | Senior Vice President of Chemistry | — |
| Dr. Fang Zhang Ph.D. | Executive VP & Head of Biology | — |
| Ms. Lani Ibarra | Senior Vice President of Clinical Development Operations | — |
Fundamentals
Valuation
Market cap$2.50B
Price-to-sales ratioN/A
Price-to-book value1.84
Price-earnings ratio-11.60
Return on Equity-15.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-3.03
Income Statement
Average volume1,113,984
EBITDA$-165.66M
1 year high (52w)$94.90
1 year low (52w)$23.59
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



